1-7 of 7
Ryan K Van Laar, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Favorable BCL-2 Family Expression Profile May Explain the Increased Susceptibility of the t(11;14) Multiple Myeloma Subgroup to Single Agent Venetoclax

Jenny Wu, Jeremy Ross, Franklin V. Peale, Jr., John D Shaughnessy, Jr., PhD, Ryan K Van Laar, PhD, Gareth J Morgan, MD PhD, Jeffrey M Venstrom, Elizabeth A. Punnoose, PhD
Journal: Blood
Blood (2016) 128 (22): 5613.
https://doi.org/10.1182/blood.V128.22.5613.5613
Published: 2016
Journal Articles

MyPRS R Molecular Subtypes of Multiple Myeloma Represent All High-Risk FISH Translocations Included in the mSMART 2.0 and R-ISS Guidelines

Ryan K Van Laar, PhD, Ivan Borrelo, MD, David Jabalayan, MSc, Ruben Niesvizky, MD, Aga Zielinski, PhD, Kenton Leigh, BS, Nathan Brown, PhD, Richard A Bender, MD
Journal: Blood
Blood (2016) 128 (22): 3264.
https://doi.org/10.1182/blood.V128.22.3264.3264
Published: 2016
Journal Articles

Promising Prognostic Values of Sequential Gene Expression Profiling in Multiple Myeloma Patients Undergoing Various Systemic Therapy

Yazan Migdady, MD MSc, Taiga Nishihori, MD, Rachid Baz, MD, Ram Thapa, PhD, Youngchul Kim, PhD, Dung-Tsa Chen, PhD, Ryan K Van Laar, PhD, Richard A Bender, MD, Siegel M Erin, PhD MPH, Vonetta Williams, PhD MPH, CTR, Michelle Fouriner, Melissa Alsina, MD, Kenneth H. Shain, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5648.
https://doi.org/10.1182/blood.V128.22.5648.5648
Published: 2016
Journal Articles

Validation of the Prognostic Significance of Gene Expression Profiling (GEP) Analysis on Myeloma Irrespective of Disease Status or Stage - a Single Center Academic Center Experience -

Taiga Nishihori, MD, Rachid Baz, MD, Ram Thapa, PhD, Youngchul Kim, PhD, Dung-Tsa Chen, PhD, Yazan Migdady, MD, Ryan K Van Laar, PhD, Richard A Bender, MD, Erin M Siegel, PhD MPH, Vonetta Williams, PhD MPH, CTR, Michelle Fournier, Melissa Alsina, MD, Kenneth H. Shain, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4417.
https://doi.org/10.1182/blood.V128.22.4417.4417
Published: 2016
Journal Articles

Validation of the Nextseq 500 and Development of a High-Throughput NGS Pipeline for Identifying Clinically-Relevant Gene Variants in Multiple Myeloma Specimens

Agnieszka K. Zielinska, PhD, Kenton Leigh, BS, Horacio Gomez, PhD, Ryan K Van Laar, PhD
Journal: Blood
Blood (2015) 126 (23): 5346.
https://doi.org/10.1182/blood.V126.23.5346.5346
Published: 2015
Journal Articles

Targeted MEK Inhibition in Patients with Previously Treated Multiple Myeloma

Christoph Heuck, MD, Yogesh Jethava, MB, MRCP, MD FRCPath, Rashid Z Khan, MD, Scott Miller, Alan Mitchell, Donald Johann, MD MS, Kelly Robbins, Ryan K Van Laar, PhD, Siraj Ali, MDPhD, Vincent A. Miller, MD, Clyde Bailey, Jeffery Sawyer, Maurizio Zangari, MD, Frits van Rhee, MD PhD, Faith E Davies, MD, Gareth J Morgan, MD PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 4775.
https://doi.org/10.1182/blood.V124.21.4775.4775
Published: 2014
Journal Articles

Exomic microRNA Profiling of Bone Marrow Aspirate Plasma and Comparison with mRNA Profiles Used in the Clinical Management of Multiple Myeloma

Ryan K Van Laar, PhD, Rachel Flinchum, MSc, Brown Nathan, MSc, Joseph Ramsey, MSc, John Shaughnessy, PhD, Joshua Epstein, PhD, Christoph Heuck, MD, Bart Barlogie, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5681.
https://doi.org/10.1182/blood.V124.21.5681.5681
Published: 2014